These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31861963)

  • 1. Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis.
    Anselmino N; Starbuck M; Labanca E; Cotignola J; Navone N; Gueron G; Zenclussen AC; Vazquez E
    Antioxid Redox Signal; 2020 Jun; 32(17):1243-1258. PubMed ID: 31861963
    [No Abstract]   [Full Text] [Related]  

  • 2. Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells.
    Ferrando M; Wan X; Meiss R; Yang J; De Siervi A; Navone N; Vazquez E
    PLoS One; 2013; 8(11):e80315. PubMed ID: 24224047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression.
    Anselmino N; Bizzotto J; Sanchis P; Lage-Vickers S; Ortiz E; Valacco P; Paez A; Labanca E; Meiss R; Navone N; Cotignola J; Vazquez E; Gueron G
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32197509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme Oxygenase 1 and 2 Differentially Regulate Glucose Metabolism and Adipose Tissue Mitochondrial Respiration: Implications for Metabolic Dysregulation.
    Yao H; Peterson AL; Li J; Xu H; Dennery PA
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
    Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
    Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer.
    Ortiz E; Sanchis P; Bizzotto J; Lage-Vickers S; Labanca E; Navone N; Cotignola J; Vazquez E; Gueron G
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32640729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic Ly6C
    Tomczyk M; Kraszewska I; Szade K; Bukowska-Strakova K; Meloni M; Jozkowicz A; Dulak J; Jazwa A
    Basic Res Cardiol; 2017 Jul; 112(4):39. PubMed ID: 28534119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.
    Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine Bone Marrow Mesenchymal Stromal Cells Respond Efficiently to Oxidative Stress Despite the Low Level of Heme Oxygenases 1 and 2.
    Nowak WN; Taha H; Kachamakova-Trojanowska N; Stępniewski J; Markiewicz JA; Kusienicka A; Szade K; Szade A; Bukowska-Strakova K; Hajduk K; Klóska D; Kopacz A; Grochot-Przęczek A; Barthenheier K; Cauvin C; Dulak J; Józkowicz A
    Antioxid Redox Signal; 2018 Jul; 29(2):111-127. PubMed ID: 29065700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice.
    Kovtunovych G; Ghosh MC; Ollivierre W; Weitzel RP; Eckhaus MA; Tisdale JF; Yachie A; Rouault TA
    Blood; 2014 Aug; 124(9):1522-30. PubMed ID: 24963040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide.
    True AL; Olive M; Boehm M; San H; Westrick RJ; Raghavachari N; Xu X; Lynn EG; Sack MN; Munson PJ; Gladwin MT; Nabel EG
    Circ Res; 2007 Oct; 101(9):893-901. PubMed ID: 17885218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using ultrasound to define the time point of intrauterine growth retardation in a mouse model of heme oxygenase-1 deficiency†.
    Meyer N; Langwisch S; Scharm M; Zenclussen AC
    Biol Reprod; 2020 Jun; 103(1):126-134. PubMed ID: 32342097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme-Oxygenase-1.
    Facchinetti MM
    Antioxid Redox Signal; 2020 Jun; 32(17):1239-1242. PubMed ID: 32148070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans.
    Wenzel P; Rossmann H; Müller C; Kossmann S; Oelze M; Schulz A; Arnold N; Simsek C; Lagrange J; Klemz R; Schönfelder T; Brandt M; Karbach SH; Knorr M; Finger S; Neukirch C; Häuser F; Beutel ME; Kröller-Schön S; Schulz E; Schnabel RB; Lackner K; Wild PS; Zeller T; Daiber A; Blankenberg S; Münzel T
    Eur Heart J; 2015 Dec; 36(48):3437-46. PubMed ID: 26516175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast.
    Ke K; Safder MA; Sul OJ; Kim WK; Suh JH; Joe Y; Chung HT; Choi HS
    Mol Cell Endocrinol; 2015 Jul; 409():11-20. PubMed ID: 25841764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.
    Wan X; Li ZG; Yingling JM; Yang J; Starbuck MW; Ravoori MK; Kundra V; Vazquez E; Navone NM
    Bone; 2012 Mar; 50(3):695-703. PubMed ID: 22173053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis.
    Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
    PLoS One; 2012; 7(3):e33011. PubMed ID: 22412975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
    Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 in macrophages controls prostate cancer progression.
    Nemeth Z; Li M; Csizmadia E; Döme B; Johansson M; Persson JL; Seth P; Otterbein L; Wegiel B
    Oncotarget; 2015 Oct; 6(32):33675-88. PubMed ID: 26418896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.